Fulgent Genetics: A Major Market Misconception (NASDAQ:FLGT)

分组1 - Fulgent Genetics experienced a significant stock decline of nearly 40% following the Q4 2025 earnings report, primarily due to the announcement of the departure of a key executive [1] - The decline in stock value may be attributed to multiple factors, indicating potential underlying issues within the company [1] 分组2 - The article reflects a value investing perspective, emphasizing the importance of identifying rare and exceptional buying opportunities in the market [1] - The author highlights a focus on deep value plays through various analytical methods, including net current asset value analysis and conservative discounted cash flow calculations [1]